Advertisement
my other posts

Oracea

Oracea Official FDA information, side effects and uses.


MediGene says EU postpones approval of skin disease treatment Oracea - Forbes
Posted by Oracea (Oracea) on Tue, 21 Aug 2007 00:15:51 +0000



MediGene says EU postpones approval of skin disease treatment Oracea
Forbes, NY -Jul 30, 2007
In the US, Oracea is already approved and has been successful on the market since 2006, MediGene said. Oracea, developed by US-based CollaGenex, ...


Decision About European Marketing Authorization for Oracea ... - PharmaLive.com (press release)

Decision About European Marketing Authorization for Oracea...
PharmaLive.com (press release), PA -Jul 30, 2007
The annual peak sales potential for Oracea® in Europe is expected to be about 20 million Euro. Dr. Peter Heinrich, Chief Executive Officer of MediGene AG, ...


CollaGenex Pharmaceuticals Reports Financial Results for the ... - Business Wire (press release)

CollaGenex Pharmaceuticals Reports Financial Results for the ...
Business Wire (press release), CA -Aug 7, 2007
Net sales of Oracea were $13.1 million in the second quarter of 2007. Net loss allocable to common stockholders for the second quarter of 2007 was $4.8 ...


Skin drug boosts CollaGenex - phillyBurbs.com

Skin drug boosts CollaGenex
phillyBurbs.com, PA -Aug 8, 2007
The company recorded $13.1 million in sales for Oracea. The oral drug used to treat the skin disease rosacea, launched in July 2006. ...


CollaGenex Pharmaceuticals (CGPI) Tops Q2 EPS by 2c, Revises ... - StreetInsider.com (subscription)

CollaGenex Pharmaceuticals (CGPI) Tops Q2 EPS by 2c, Revises ...
StreetInsider.com (subscription), MI -Aug 7, 2007
Total revenues: Revenues from Oracea, Periostat®, Pandel, the Atrix products, contract revenues from the Primus products and grant revenue from the ...